GlassScriptPhysician profile
Merajur Rahman
NPI 1891010732
$1,994.94
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $264 · 2021: $339 · 2022: $527 · 2023: $349 · 2024: $59.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.55 | 2019-2024 | |
| Intra-Sana Laboratories | $337.19 | 2022-2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Redhill Biopharma INC. | $228.28 | 2020-2024 | Talicia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.39 | 2019-2023 | Xifaxan |
| Gilead Sciences, INC. | $109.83 | 2019-2020 | |
| Qol Medical, LLC | $90.54 | 2019-2021 | |
| Capsovision, INC. | $75.65 | 2023 | Capsocam Plus |
| Celgene Corporation | $43.58 | 2023 | Zeposia |
| Pfizer INC. | $40.51 | 2023 | |
| Allergan, INC. | $36.81 | 2019 | |
| Alfasigma USA, INC. | $32.52 | 2020 | |
| Intercept Pharmaceuticals, INC. | $25.15 | 2019 | |
| Janssen Biotech, INC. | $20.00 | 2021 | |
| Ironwood Pharmaceuticals, INC | $18.70 | 2019 | |
| Merck Sharp & Dohme LLC | $18.68 | 2023 | Dificid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.59 | 2023 | Cologuard Collection Kit |
| Braintree Laboratories, INC. | $16.42 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merajur Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.